CMRA Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume38.00
Average Volume (3M)N/A
Market Cap
$3.07K
Enterprise Value$331.51B
Total Cash (Recent Filing)$1.77M
Total Debt (Recent Filing)$171.60K
Price to Earnings (P/E)―
Beta121.60
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding30,737,797
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.06
Price to Sales (P/S)20.31
P/FCF Ratio-1.31
Enterprise Value/Market Cap107.84M
Enterprise Value/Revenue331.38K
Enterprise Value/Gross Profit450.72K
Enterprise Value/Ebitda-37.32K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Comera Life Sciences Holdings News
CMRA FAQ
What was Comera Life Sciences Holdings’s price range in the past 12 months?
Comera Life Sciences Holdings lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Comera Life Sciences Holdings’s market cap?
Comera Life Sciences Holdings’s market cap is $3.07K.
When is Comera Life Sciences Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Comera Life Sciences Holdings’s earnings last quarter?
Comera Life Sciences Holdings released its earnings results on Nov 09, 2023. The company reported -$0.097 earnings per share for the quarter.
Is Comera Life Sciences Holdings overvalued?
According to Wall Street analysts Comera Life Sciences Holdings’s price is currently Overvalued.
Does Comera Life Sciences Holdings pay dividends?
Comera Life Sciences Holdings does not currently pay dividends.
What is Comera Life Sciences Holdings’s EPS estimate?
Comera Life Sciences Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Comera Life Sciences Holdings have?
Comera Life Sciences Holdings has 30,737,797 shares outstanding.
What happened to Comera Life Sciences Holdings’s price movement after its last earnings report?
Comera Life Sciences Holdings reported an EPS of -$0.097 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Comera Life Sciences Holdings?
Currently, no hedge funds are holding shares in CMRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Comera Life Sciences Holdings
Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progressing two main product candidates: CLS-001, an early-stage "biobetter" designed to treat inflammatory bowel conditions like Crohn's and Ulcerative Colitis, and CLS-002, another preclinical biobetter aimed at diverse oncology indications. Established in 2014, Comera Life Sciences is headquartered in Woburn, Massachusetts.
Technical Analysis
Co-Diagnostics
―
Genprex
―
BioRestorative Therapies
―
Bolt Biotherapeutics
―
Onconetix
―
Ownership Overview
―
Insiders
―
Mutual Funds
1.03% Other Institutional Investors
98.97% Public Companies and
Individual Investors